Prosecution Insights
Last updated: November 04, 2026
Application No. 18/210,699

COAXIAL MICRO-ENDOSCOPE

Final Rejection §103§112
Filed
Jun 16, 2023
Priority
Nov 10, 2012 — provisional 61/724,922 +3 more
Examiner
VU, QUYNH-NHU HOANG
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Agile Devices, Inc.
OA Round
4 (Final)
69%
Grant Probability
Favorable
5-6
OA Rounds
1m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allowance Rate
690 granted / 1005 resolved
-1.3% vs TC avg
Strong +27% interview lift
Without
With
+27.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
46 currently pending
Career history
1057
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
44.0%
+4.0% vs TC avg
§102
19.5%
-20.5% vs TC avg
§112
27.4%
-12.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1005 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Response to Amendment The amendment filed on 08/05/26 has been entered in the case. Claims 25, 28-29, 32, 35, 37, 40, 44, 47, 51-52 are pending for examination; claims 48-49 are withdrawn and claims 1-24, 26-27, 30-31, 33-34, 36, 38-39, 41-43, 45-46, 50 & 53 are cancelled. 1) The Examiner noted a Correction of Election/Restriction in previous Non-Final Rejection 03/09/26; please see the marked-up figure above. During the interview on 02/08/26 & 02/19/26, Attorney Neil Gershon agreed to amend claim 28. Consequently, claim 28 is currently being examined based on that agreed-upon amended limitation. However, in the present response to the Non-Final Office Action 03/09/26, claim 28 remains identical to its originally filed version. It is therefore unclear whether the Applicant intends to retain claim 28 as originally filed or to amend it as previously discussed. The Applicant is requested to clarify this matter and confirm the status of claim 28. Claims 48-49 require that: a plurality of exits for fluid introduction; wherein the exits are in the outer tubular member or the inner tubular member. These limitations are designated to non-elected Fig. 15. Therefore, claims 48-48 are withdrawn. PNG media_image1.png 337 776 media_image1.png Greyscale PNG media_image2.png 338 784 media_image2.png Greyscale 2) During the interviews on 02/18/26 and 02/19/26, the Applicant re-elected species 8 (Fig. 7). However, based on the Remarks filed on 08/05/26 (see below), the Applicant included the non-elected Fig. 28 in this argument. Note that the non-elected Fig. 28 is a different embodiment from the elected species 8 (Fig. 7). PNG media_image3.png 242 774 media_image3.png Greyscale Note: To clarify the record, the Applicant is requested to confirm in the next response whether the intended election is Fig. 7 or Fig. 14 (as original election in 01/17/25). Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 25, 28-29, 32-33, 35, 37, 40, 44, 46-47, 50-52 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. The limitation “the imaging device positioned at distal end of the endoscope such that it does not extend beyond the distal most end of the endoscope, the housing of the imaging device in contact with the inner tubular member” in claim 40 is failing to comply with the written description requirement in elected Fig. 7. Oppositely, the elected Figs. 7 & reproduced Fig. 7A show that the imaging device 46 extends (radially or in vertical direction in Fig. 7) beyond a distal most end of the endoscope; and when the housing of the imaging device in contact with the inner tubular member 122, as shown in reproduced Fig. 7A, the imaging device 46 extends beyond the distal most end 118 of the endoscope (in radial direction, on the left side of the distal end 118). PNG media_image4.png 464 938 media_image4.png Greyscale PNG media_image5.png 253 571 media_image5.png Greyscale Note: During the interview on 02/18/26-02/20/26, the Examiner believed that the limitation above is suitable in Fig. 28. However, the attorney Gershon disagrees and still elected Fig. 7. Since the Applicant disagrees with Examiner’s statement above, the Applicant is requested to identify the specific claim limitations supported in the elected Fig. 7. The Applicant should amend claimed invention that align with the elected Fig. 7. Response to Applicant’s argument, see below: PNG media_image3.png 242 774 media_image3.png Greyscale In response, the Applicant included the non-elected Fig. 28 in this argument. Note that the non-elected Fig. 28 is a different embodiment from the elected species 8 (Fig. 7). The examiner acknowledges that the imaging device 46 is attached to the distal end of the outer catheter. As indicated above, the imaging device 46 extends beyond the absolute distal end of the endoscope. This configuration contradicts the claimed invention, where the imaging device does not extend beyond the distal-most end of the endoscope. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of pre-AIA 35 U.S.C. 103(a) which forms the basis for all obviousness rejections set forth in this Office action: (a) A patent may not be obtained though the invention is not identically disclosed or described as set forth in section 102, if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 25, 28-29, 32, 35, 37, 40, 44, 48-52 are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Salahieh et al. (US 2010/0331776) in view of Adair (US 6,086,528). Regarding claim 40, Salahieh discloses a steerable & insertable device 30 into a patient comprising: Note: it is well-known in the art that the steerable catheter is being used in endoscope. Therefore, the insertable device 30 is fair enough to call as endoscope device. an outer tubular member 34 having a proximal portion, a distal portion, a distal opening, a longitudinal axis and a first lumen; and an inner tubular member 36 having a second lumen and a distal opening, the inner tubular member coaxially positioned within the first lumen of the outer tubular member, the inner tubular member disposed in the first lumen of the outer tubular for axial movement of one or both of the inner tubular member and outer tubular member (the D & P arrows, in Fig. 2b, the inner tubular member 36 attached to the outer tubular member 34 (at fixation location 38) so a distal region of the outer tubular member is joined to a distal region of the inner tubular member, para [0067] & Fig. 2b; wherein axial movement of one or both of the inner tubular member and outer tubular member causes deflection of a distal end of the endoscope wherein one or both of: a) the inner tubular member is axially movable within the first lumen of the outer tubular member in one axial direction to cause deflection of the distal end of the endoscope laterally in a first direction (in Fig. 2a) and the inner tubular member is axially movable in an opposite axial direction within the outer tubular member to cause deflection of the distal end of the endoscope laterally in a second direction (in Fig. 2b) opposite the first direction; or b) the outer tubular member is axially movable over the inner tubular member in one longitudinal direction to cause deflection of the distal end of the endoscope laterally in the first direction (in Fig. 2a) and the outer tubular member is axially movable over the inner tubular member in an opposite longitudinal direction to cause deflection of the distal end of the endoscope laterally in the second direction (in Fig. 2b) opposite the first direction; and Salahieh does not disclose that an imaging device including a housing, the imaging device positioned at a distal end of the endoscope such that it does not extend beyond a distal most end of the endoscope, the housing of the imaging device in contact with the inner tubular member, wherein deflection of the endoscope moves the imaging device in direction of deflection. Adair discloses an endoscope device 10 comprising: an outer tubular member 12; an inner tubular member 27; an imaging device 20 including a housing (element 25 & a distal portion/sleeve of the inner tubular member) positioned at a distal end of the endoscope such that it does not extend beyond a distal most end of the endoscope, the housing (located at distal portion of the inner tubular member 27) of the imaging device in contact with the inner tubular member 27, wherein deflection of the endoscope moves the imaging device in direction of deflection. PNG media_image6.png 393 935 media_image6.png Greyscale It would have been obvious at the time the invention was made to a person having ordinary skill in the art to modify the device of Salahieh with providing an image unit located at distal end of the endoscope that does not extend beyond a distal most end of the endoscope, as taught by Adair, in order to capture an image from a different angle and provide a forward view of body cavity. Note: The Salahieh discloses that the distal tip region of the endoscope being deflected; wherein the imaging device (as modified by Adair) is located at distal end of the endoscope; therefore, the deflection of the endoscope moves the imaging device in direction of deflection. Regarding claim 25, Salahieh in view of Adair discloses the invention substantially as claimed. Adair discloses that wherein the imaging device 60 includes a complementary metal oxide semiconductor module, col. 3, lines 45-47. Regarding claim 28, Salahieh in view of Adair discloses the invention substantially as claimed. Salahieh also discloses that inner tubular member 36 can have at least one slot formed therein, para [0079]. Adair discloses that: in addition to light fibers 27, fluid can be introduced through one or more of the channels 26 in order to flush, col. 5, lines 57-59. It is noted that the channel 26 is located within the inner tubular member. Therefore, Adair (or Salahieh in view of Adair) discloses that a gap 26/27 is formed in between the inner tubular member and outer tubular member for irrigation (and/or aspiration for intended use purpose). Regarding claims 29 & 32, Salahieh in view of Adair discloses the invention substantially as claimed. Salahieh discloses that a guidewire (is same as a removable wire in claim 32) is advanced to a desired location within the subject, para [0132]. It is well-known in the art that the guidewire being used in the endoscope device. Therefore, a person skilled in the art would recognize that the inner/second lumen 36 can be used for passage of a guidewire or removable wire. The removable wire can be performed to ad introduction of the endoscope. Regarding claim 35, Salahieh in view of Adair discloses the invention substantially as claimed. Adair further states that: in addition to light fibers, other device, i.e. guidewire is passed through the small lumens or channels 26, col. 5, lines 24-26. Salahieh also a lubricious inner line being provided for a medical device or instrument to be advanced therethrough, paras [0071-0072]. Therefore, a person skilled in the art would recognize that the channel 26 (as being used for the guidewire channel passing through) is being provided a lubricous inner liner, as suggested by Salahieh, to facilitate guidewire movement easily within the endoscope. Regarding claim 37, Salahieh in view of Adair discloses the invention substantially as claimed. Salahieh in view of Adair further discloses that wherein the imaging device includes a camera and lighting includes an optical fiber. Regarding claim 44, Salahieh in view of Adair discloses the invention substantially as claimed. Salahieh in view of Bayer further discloses that wherein the inner tubular member is lockable (at fixation location 38 in Fig. 1-2 in Salahieh) to the outer tubular member. Regarding claims 48-49, Note: The Examiner finds the Applicant's election of Figure 7 or Figure 14 confusing. At this stage, the features of claims 48 and 49 were already addressed under claim 28 in the previous Non-Final Rejection 03/09/26 (see below). PNG media_image7.png 387 798 media_image7.png Greyscale Salahieh discloses a plurality of slots/holes 50. Adair discloses the channel 26 can be used to flush or introduce a fluid. Therefore, Salahieh in view of Adair discloses that a plurality of exits 510 (in Salahieh) for fluid introduction; wherein the exits 510 are in the outer tubular member. Regarding claim 51, Salahieh in view of Adair discloses the invention substantially as claimed. Adair discloses that wherein the imaging device includes transmission members, i.e., #14, 18 & 19 in Fig. 2A, extending proximally, wherein the transmission members extend through the first lumen in the outer member. Note: Adair discloses the transmission members extend through the inner lumen and also extend through the first lumen 26 in the outer member 12, see Fig. 2A. Regarding claim 52, Salahieh in view of Adair discloses the invention substantially as claimed. Salahieh discloses that the inner tubular member is formed from a laser cut tube, see Fig. 8. Claim 47 is rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Salahieh et al. (US 2010/0331776) in view of Adair (US 6,086,528) and further in view of Corcoran et al. (US 2006/0241564). Regarding claim 47, Salahieh in view of Adair discloses the invention substantially as claimed except for the limitations in the claim 47. Corcoran discloses a steerable catheter device comprising: an outer tubular member 2; an inner tubular member 3 having a second lumen 11 is used for passage of a guidewire, para [0068]; wherein the first lumen of the outer tubular member is lubricated a coating 14 to facilitate movement of the inner tubular member within the outer tubular member, para [0070]. It would have been obvious at the time the invention was made to a person having ordinary skill in the art to modify the device of Salahieh in view of Adair with obtaining a lubricious inner liner being formed between the inner and outer tubular members, as taught by Corcoran, in order to facilitate movement of the inner tubular member within the outer tubular member easily. Response to Arguments Applicant's arguments filed 08/05/26 have been fully considered but they are not persuasive. In response to applicant's arguments against the references individually, one cannot show nonobviousness by attacking references individually where the rejections are based on combinations of references. See In re Keller, 642 F.2d 413, 208 USPQ 871 (CCPA 1981); In re Merck & Co., 800 F.2d 1091, 231 USPQ 375 (Fed. Cir. 1986). In this case, while Salahieh does not disclose an imaging device positioned at the distal end of the endoscope, Adair compensates for this missing feature. Adair discloses an imaging device 20 provided at the distal end of the endoscope to capture an image from a different angle and provide a forward view of a body cavity. The Applicant argues that Adair fails to disclose coaxial inner and outer tubular members, or their relative movement to deflect the endoscope. However, as discussed in the rejection the above, Salahieh clearly discloses this claimed feature. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to QUYNH-NHU HOANG VU whose telephone number is (571)272-3228. The examiner can normally be reached M-F 7:30 am-4:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Tsai can be reached at 571-270-5246. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /QUYNH-NHU H. VU/ Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Show 4 earlier events
Jun 20, 2025
Response Filed
Jul 11, 2025
Final Rejection mailed — §103, §112
Jan 02, 2026
Request for Continued Examination
Feb 15, 2026
Response after Non-Final Action
Feb 18, 2026
Examiner Interview (Telephonic)
Mar 09, 2026
Non-Final Rejection mailed — §103, §112
Aug 05, 2026
Response Filed
Aug 26, 2026
Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12779097
ISOLATED WEARABLE BREAST PUMP
3y 2m to grant Granted Nov 03, 2026
Patent 12773495
SKIN PATCH DRUG INFUSION DEVICE
3y 4m to grant Granted Oct 27, 2026
Patent 12758705
FLEXIBLE LINKAGE FOR POSITIVE DISPLACEMENT PUMPS
3y 12m to grant Granted Oct 13, 2026
Patent 12746331
Vial Transfer and Injection Apparatus and Method
5y 4m to grant Granted Sep 29, 2026
Patent 12743269
AMBULATORY MEDICAL DEVICE WITH MALFUNCTION ALERT PRIORITIZATION
2y 7m to grant Granted Sep 22, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
69%
Grant Probability
96%
With Interview (+27.3%)
3y 6m (~1m remaining)
Median Time to Grant
High
PTA Risk
Based on 1005 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month